NeuroTech Insights - Comprehensive Analysis Report

Summary

NeuroTech Insights is a healthcare technology company dedicated to revolutionizing neurofunctional health. Its mission is to empower healthcare providers with the tools to effectively understand, treat, and measure neurofunctional health through accurate assessments, remote patient monitoring, and AI-generated treatment insights. The company's vision is to make best-in-class treatments for neurological conditions universally accessible and beneficial. Formed from the strategic merger of SportGait and Heads Together Health, NeuroTech Insights combines validated assessments with AI-driven treatment tools to deliver a comprehensive, connected care experience, spanning from initial baseline testing to full reintegration. The company plays a crucial role in addressing the inconsistencies and lack of data-driven tools in current neurological and movement condition care, aiming to improve diagnostic accuracy and optimize treatment outcomes.

1. Strategic Focus & Objectives

Core Objectives

NeuroTech Insights is focused on revolutionizing neurofunctional prehabilitation, performance, and recovery. Its main business objectives include offering accurate cognitive and gait assessments, facilitating robust remote patient monitoring, and providing personalized, AI-driven treatment recommendations. The company aims to establish a new standard for neurological care by providing data-driven tools that improve diagnosis, treatment, and management of neurological disorders.

Specialization Areas

The company specializes in providing integrated, AI-driven solutions for neurofunctional health. Key areas of expertise include objective assessment of dynamic postural stability, balance, and cognitive functions using proprietary BKG™ Gait Technology and CPT Cognitive Assessments. They also specialize in developing mobile platforms for remote patient assessments, treatment guidance, adherence reporting, and symptom tracking, along with intuitive clinician web portals and EMR integration. A unique value proposition lies in its "test-agnostic" approach, integrating only clinically valid, reliable, and easy-to-administer assessments.

Target Markets

NeuroTech Insights targets a broad spectrum of neurological and movement conditions, including concussions, back pain, and Parkinson's disease. Additionally, the company addresses issues such as stress, anxiety, and depression through integrated neurobehavioral tools. Its integrated platform supports the entire care journey, catering to both patients and healthcare providers managing these conditions.

2. Financial Overview

Funding History

NeuroTech Insights is currently an unfunded company, having not raised any external funding rounds to date.

3. Product Pipeline

Key Products/Services

NeuroTech Insights offers a comprehensive, all-in-one neurofunctional health solution that integrates advanced assessments with AI-driven treatment tools.

BKG™ Gait Technology: A proprietary assessment tool that objectively measures dynamic postural stability and balance. This technology provides data-rich insights into neurological, cardiovascular, and musculoskeletal health, treating gait as a "6th vital sign."
CPT Cognitive Assessments: Proprietary neurocognitive assessments designed to objectively measure cognitive functions.
Mobile Platform: A cutting-edge mobile application that incorporates BKG™ Gait Technology and CPT Cognitive Assessments, alongside screeners for stress, anxiety, and depression.
Key Features and Benefits: Supports remote patient assessments, provides treatment guidance, generates adherence reports, and facilitates real-time symptom tracking. This empowers patients with accessible tools and enables providers to monitor progress effectively.
AI-Powered Insights: Central to the platform, AI algorithms analyze structured data from assessments and monitoring to provide personalized, data-informed treatment plans. This also accelerates the development of biomarkers for various conditions, enhancing diagnostic and treatment precision.
Clinician Web Portal: An intuitive web-based interface for healthcare providers, offering customized workflows.
Key Features and Benefits: Enables baseline assessments, injury tracking, symptom logging, analysis of exam results, robust treatment planning, and seamless Electronic Medical Record (EMR) integration.
Patient Recovery Monitoring Dashboard: A dedicated dashboard to track and visualize patient recovery progress, supporting ongoing management and reintegration.
Development Stage: The integrated system is operational and actively utilized in select clinics, demonstrating early validation and positive reception.

4. Technology & Innovation

Technology Stack

NeuroTech Insights' technology platform is built on the integration of validated assessments and advanced AI-driven tools.
Core Platforms and Technologies: The company utilizes proprietary BKG™ Gait Technology for objective dynamic postural stability and balance measurements, and CPT Cognitive Assessments for neurocognitive evaluations. These assessments are administered through a cutting-edge mobile app.
Proprietary Developments: Beyond BKG™ Gait and CPT Cognitive Assessments, the company's proprietary approach extends to its AI-powered insights engine, which processes structured data to generate personalized treatment plans and accelerate biomarker development.
Scientific Methodologies: The platform is built on years of validated science, ensuring the clinical validity, reliability, and ease of administration of all incorporated assessments. The company adopts a "test-agnostic" philosophy, emphasizing evidence-based tools.
Technical Capabilities: The system offers robust remote patient assessment capabilities, secure data collection, adherence reporting, symptom tracking, and seamless EMR integration via an intuitive clinician web portal.

5. Leadership & Management

Executive Team

Chris Newton, MS - Chief Executive Officer (CEO)
Chris Newton leads NeuroTech Insights in corporate and product strategy, operations, regulatory compliance, and sales & marketing. He previously served as CEO of SportGait, where he was instrumental in developing the company's mobile platform and BKG Gait and neurocognitive assessments.
Steve DeVrieze, MBA - Chief Business Officer (CBO)
Steve DeVrieze brings over 20 years of experience in management consulting, technology deployment, and healthcare services. Prior to the merger, he was the CEO of Heads Together Health, a company specializing in concussion management and AI-powered data platforms.
Kevin Carneiro, DO - Chief Scientific Officer (CSO)
Kevin Carneiro is responsible for establishing the scientific foundation of NeuroTech Insights' technology. He emphasizes that the company's technology is grounded in validated science, enabling personalized and precise care for conditions ranging from concussions to identifying recovery phenotypes.

Special Advisors:
NeuroTech Insights benefits from the expertise of former NFL players Luke Kuechly and Merril Hoge, who serve as Special Advisors. They contribute their firsthand experiences and advocate for brain health and concussion awareness, helping to shape the company's vision and expand its impact within the sports and medical communities.

Recent Leadership Changes

NeuroTech Insights was formed in February 2025 through the strategic merger of Wilmington-based SportGait and Chapel Hill's Heads Together Health. This unification brought together the leadership teams of both companies. Chris Newton, formerly CEO of SportGait, assumed the role of CEO of NeuroTech Insights. Steve DeVrieze, previously CEO of Heads Together Health, became the Chief Business Officer.

6. Talent and Growth Indicators

Hiring Trends and Workforce

As of January 31, 2026, NeuroTech Insights has an employee count of 13. The company’s formation through a strategic merger indicates a current focus on consolidating and integrating existing teams while building out a comprehensive platform. Growth trajectory suggests a potential for expansion as its integrated platform gains wider adoption in clinics and the market expands.

7. Social Media Presence and Engagement

Digital Footprint

NeuroTech Insights maintains a digital presence, particularly on platforms like YouTube. The company utilizes YouTube to announce significant corporate developments, such as its formation through the merger of SportGait and Heads Together Health.
Brand Messaging and Positioning: Key messaging emphasizes the company's dedication to making advanced neurofunctional care accessible and improving lives through innovative solutions and compassionate support.
Thought Leadership Initiatives: Content often highlights critical topics such as brain health, neurofunctional health, healthcare innovation, concussions, and neuroscience, positioning NeuroTech Insights as a thought leader in the neurotechnology space.
Social Media Profile:
YouTube: [https://www.youtube.com/@neurotechinsightsnc](https://www.youtube.com/@neurotechinsightsnc)

9. Competitive Analysis

Major Competitors

NeuroTech Insights operates in a competitive market with numerous players. It ranks 22nd among 58 active competitors, indicating a niche but growing presence.

Wellvana: A notable competitor in the broader healthcare technology landscape.
SRx Health: Another significant competitor.
SONIFI Health: A competitor primarily focused on healthcare engagement solutions.
Neurotech (India-based): This company operates in the broader neurotechnology market, often focusing on brain training wearables.
BIOS: A company active in developing neural interfaces and AI for reading and writing neural data.
Blackrock Neurotech: Known for advanced neural implants and brain-computer interface technologies.
Other Competitors: This category includes companies offering neuromodulation technologies for various neurological disorders and those developing consumer-grade EEG devices for cognitive enhancement and wellness.

NeuroTech Insights differentiates itself by offering an end-to-end neurofunctional health solution that integrates advanced assessments, remote monitoring, and AI-driven treatment plans across a wide array of conditions, with a focus on clinically validated, "test-agnostic" assessments.

10. Market Analysis

Market Overview

The broader neurotechnology market is experiencing substantial growth, driven by key advancements and rising demand for neurological health solutions.
Total Addressable Market Size: The global NeuroTechnology market was valued at $13 billion in 2022.
Growth Potential: Projections indicate significant growth, with the market expected to reach around $38 billion by 2032, demonstrating a Compound Annual Growth Rate (CAGR) of 11.5% from 2023 to 2032. Some forecasts suggest the market could reach $50 billion by 2034.
Key Market Trends:
AI Integration: Advancements in AI are driving new solutions and insights, increasing accessibility beyond traditional clinical settings.
Prevalence of Neurological Disorders: The rising incidence of neurological conditions fuels the demand for innovative diagnostic and treatment tools.
Technological Convergence: Ongoing advancements in neuroscience, hardware, and artificial intelligence are accelerating market expansion.
Investment and Government Support: Growing interest from investors and government funding further stimulates market growth.
Consumer Accessibility: Evolution from purely clinical applications to consumer-accessible tools.
Multimodality Integration: Integration of multiple modalities for deeper insights into brain function.
Non-Pharmaceutical Alternatives: Emergence of non-pharmaceutical options for conditions like sleep disorders.
Market Challenges and Opportunities: Ethical considerations regarding neural data privacy and "neurorights" are becoming increasingly prominent challenges that need to be addressed. Opportunities primarily lie in further integrating cutting-edge technology with personalized care, empowering both patients and providers, and leveraging structured data analysis to accelerate biomarker development.

11. Strategic Partnerships

NeuroTech Insights was formed through a significant strategic collaboration and continues to leverage key partnerships.
SportGait and Heads Together Health: The company itself is a product of the strategic merger of industry leaders SportGait and Heads Together Health in February 2025. This unification synergized SportGait’s validated assessment capabilities with Heads Together Health’s AI-driven treatment solutions, forming the foundation of NeuroTech Insights.
TBRx: NeuroTech Insights has established a partnership with TBRx, indicating collaborative efforts to expand its reach or capabilities.
Luke Kuechly and Merril Hoge: Former NFL players Luke Kuechly and Merril Hoge serve as Special Advisors, leveraging their personal experiences and advocacy for brain health and concussion awareness to contribute to the company's vision and expand its influence within both sports and medical communities.

12. Operational Insights

NeuroTech Insights has positioned itself strategically within the neurofunctional health market.
Current Market Position: The company currently ranks 22nd among 58 active competitors, indicating an emergent and growing presence in the specialized neurotechnology sector.
Competitive Advantages: Its primary competitive advantage lies in offering a comprehensive, end-to-end neurofunctional health solution that integrates advanced assessments, remote monitoring, and AI-driven treatment plans. The "test-agnostic" approach ensures that only clinically valid, reliable, and easy-to-administer assessments are incorporated, distinguishing it from competitors. The emphasis on gait as a "6th vital sign" provides objective, data-rich insights into neurological, cardiovascular, and musculoskeletal health.
Operational Strengths: The integrated system is already operational in select clinics, demonstrating early validation and positive reception. This indicates an effective deployment strategy and successful initial adoption, improving care standardization, efficiency, and patient outcomes. The robust mobile platform and clinician web portal support efficient workflows and seamless EMR integration.
Areas for Improvement: As an unfunded company, securing capital will be crucial for scaling operations, expanding market reach, and further developing its technology. Continued focus on navigating the ethical considerations surrounding neural data privacy will also be important.

13. Future Outlook

Strategic Roadmap

NeuroTech Insights is strategically positioned for significant growth, aiming to capitalize on the increasing demand for advanced neurofunctional healthcare solutions.
Planned Initiatives: The company plans to continue integrating cutting-edge technology with personalized care solutions, empowering both patients and providers. A key initiative involves optimizing the brain-body connection for improved everyday performance and solidifying its role in redefining neurofunctional care.
Growth Strategies: Growth will be driven by expanding the adoption of its comprehensive, integrated platform for assessment, treatment, and recovery, powered by AI. The commitment to adapting to evolving scientific advancements will ensure the platform remains extensive and flexible.
Expansion Opportunities: Opportunities for expansion include broadening its reach into more clinics and healthcare systems, enhancing its AI capabilities to accelerate biomarker development for various neurological conditions, and potentially exploring new applications for its validated assessment technologies.
* Future Challenges and Mitigation Strategies: Key challenges will include securing necessary funding to scale and innovate, navigating the competitive landscape, and addressing ethical and regulatory considerations related to neural data. Mitigation strategies will involve demonstrating strong clinical outcomes, fostering strategic partnerships, and maintaining a robust scientific foundation for its technologies.